Find your next paid study

Fred Hutchinson Cancer CenterNCT07803653

~$10 – $6,250

Ventricular ArrythmiaVentricular FibrillationVentricular Tachycardia

Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

The ALARION EV Study is a prospective, multi-center, single-arm, non-randomized study without concurrent or historical controls. The purpose of this pivotal st…

AtaCor Medical, Inc.NCT07324031

Stroke Training to Advance Balance During Locomotor Experiences (STABLE) Trial

The goal of this clinical trial is to learn if a treadmill gait training performed with a new robotic device will improve walking balance and everyday particip…

Stroke

Northwestern UniversityNCT07802470

~$10 – $6,250

Phase 1

A First-in-human, Open-label (Part 1), Randomized (Part 2), Phase I/IIa Trial to Study Safety and Tolerability of Multiple Rising Intravitreal Doses of BI 3812465 in Patients With Center-involved Diabetic Macular Edema

This study is open to adults with diabetic macular edema that involves the center of the eye. The purpose of this study is to find out how well different doses…

Diabetic Macular Edema

Boehringer IngelheimNCT07553429

~$10 – $7,500

Phase 1

A Phase 1, First in Human Study of CTIM-76, a Claudin-6 (CLDN6)-Directed Bispecific Antibody, in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and efficacy of CTIM-76 (study drug), a CLDN6-directed T cell-eng…

Platinum-resistant Ovarian CancerTesticular CancerEndometrial Cancer

Context Therapeutics Inc.NCT06515613

Phase 2

Third Party Viral Specific T-cells (VSTs) for Treatment of Viral Infections in Immunocompromised Patients

The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely …

Viral InfectionViral ReactivationInfection in an Immunocompromised Host

Children's Hospital Medical Center, CincinnatiNCT02532452

~$10 – $5,625

Phase 3

A Prospective, Randomized, Double-Blinded, Sham-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of IDCT in Subjects With Single-Level, Symptomatic Mild to Moderate Lumbar Intervertebral Disc Degeneration

This is a Phase III, randomized, double-blinded, Sham-controlled, multi-center study in subjects with single-level, symptomatic lumbar (L3- S1) intervertebral …

Degenerative Disc Disease

DiscGenics, Inc.NCT07254806

Prospective, Randomized, Controlled Trial to Evaluate the Effect of Preoperative Penile Traction Therapy on Post-penile Implant Length and Patient Satisfaction

The goal of this study is to determine whether or not the use of a penile traction therapy device known as RestoreX prior to implantation of a penile prosthesi…

Erectile Dysfunction

J. Peter Rubin, MDNCT07053826

~$10 – $7,500

Durability of Yoga for Treating Veterans With Chronic Low Back Pain

Chronic low back pain is a prevalent condition among VA patients, but many current treatment options have side effects or limited effectiveness. Veterans with …

Chronic Low Back Pain

VA Office of Research and DevelopmentNCT07053787

~$10 – $5,625

Phase 1

A Phase 1b, Multicenter, Dose Escalation, Evaluation of Safety and Tolerability of ASP7317 for Geographic Atrophy Secondary to Age-related Macular Degeneration

Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is i…

Age-Related Macular Degeneration

Astellas Institute for Regenerative MedicineNCT03178149

~$10 – $7,500

Phase 3

A Phase 3 Open-Label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment With a CDK4/6 Inhibitor

This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 (zovegalisib) + fulvestrant to capivasertib +…

PIK3CA MutationHER2- Negative Breast CancerHormone Receptor Positive Tumor+3 more

Relay Therapeutics, Inc.NCT06982521

Phase 2

STudy of Real-world Individualized Precision-oncology

The goal of this clinical trial is to learn if drugs that are matched to tumor DNA mutations work to treat metastatic solid cancers in adults. The main questio…

Metastatic CancerUnresectable Carcinoma